Superworth

Phio Pharmaceuticals EPS PHIO

Diluted earnings per share by quarter and over the last twelve months, from 2011.

Last 12 months, to Jun 30, 2025
−$3.83
Latest quarter, Q2 FY25
−$0.45
Fiscal year 2024
−$10.82

Phio Pharmaceuticals' earnings per share was −$3.83 over the twelve months to Jun 30, 2025.

In its latest quarter, Q2 FY25, it was −$0.45.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2024−$10.82n/a
FY2023−$57.56n/a
FY2022−$91.26n/a
FY2021−$113.40n/a
FY2020−$268.92n/a
FY2019−$2111.40n/a
FY2018−$10692.00n/a
FY2017−$33620.40n/a
FY2016−$96049.80n/a
FY2015−$154440.00n/a
FY2014−$504900.00n/a
FY2013−$2239380.00n/a
FY2012−$23754060.00n/a
FY2011−$180873000.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY25−$0.45n/a−$3.83
Q1 FY25−$0.41n/a−$7.00
Q4 FY24−$1.43n/a−$10.82
Q3 FY24−$1.54n/a−$15.08
Q2 FY24−$3.62n/a−$23.79
Q1 FY24−$4.23n/a−$33.44
Q4 FY23−$5.69n/a−$57.56
Q3 FY23−$10.25n/a−$73.47
Q2 FY23−$13.27n/a−$91.30
Q1 FY23−$28.35n/a−$98.55
Q4 FY22−$21.60n/a−$91.26
Q3 FY22−$28.08n/a−$96.66

Against its peers

Companies in Drug Manufacturers - General nearest Phio Pharmaceuticals' size, closest first, today.

CompanyEPS, 12 monthsGrowth
PHIOPhio Pharmaceuticalsn/m
ATNMActinium Pharmaceuticals$0.36
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
Peer median$0.36

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Phio Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.